These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12574149)

  • 41. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
    Chinetti-Gbaguidi G; Staels B
    Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.
    Marx N; Sukhova GK; Collins T; Libby P; Plutzky J
    Circulation; 1999 Jun; 99(24):3125-31. PubMed ID: 10377075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.
    Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S
    Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.
    Huss JM; Levy FH; Kelly DP
    J Biol Chem; 2001 Jul; 276(29):27605-12. PubMed ID: 11371554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells.
    Taniguchi S; Yanase T; Kobayashi K; Takayanagi R; Nawata H
    Atherosclerosis; 1996 Sep; 126(1):143-54. PubMed ID: 8879442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased inducibility of TNF expression in lipid-loaded macrophages.
    Ares MP; Stollenwerk M; Olsson A; Kallin B; Jovinge S; Nilsson J
    BMC Immunol; 2002 Oct; 3():13. PubMed ID: 12366867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sphingosine inhibits sphingomyelinase-induced cholesteryl ester formation in cultured fibroblasts.
    Härmälä AS; Pörn MI; Slotte JP
    Biochim Biophys Acta; 1993 Dec; 1210(1):97-104. PubMed ID: 8257725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages.
    Watanabe T; Suguro T; Kanome T; Sakamoto Y; Kodate S; Hagiwara T; Hongo S; Hirano T; Adachi M; Miyazaki A
    Hypertension; 2005 Oct; 46(4):738-44. PubMed ID: 16172428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone blocks intracellular translocation of free cholesterol derived from cholesteryl ester in macrophages.
    Mazzone T; Krishna M; Lange Y
    J Lipid Res; 1995 Mar; 36(3):544-51. PubMed ID: 7775866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.
    Cabrero A; Alegret M; Sánchez RM; Adzet T; Laguna JC; Vázquez M
    FEBS Lett; 2000 Oct; 484(1):37-42. PubMed ID: 11056218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action.
    Zhang J; Kris-Etherton PM; Thompson JT; Hannon DB; Gillies PJ; Heuvel JP
    J Nutr Biochem; 2012 Apr; 23(4):400-9. PubMed ID: 21658928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells.
    Persson J; Nilsson J; Lindholm MW
    BMC Immunol; 2008 Nov; 9():70. PubMed ID: 19032770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration.
    Rodríguez C; Noé V; Cabrero A; Ciudad CJ; Laguna JC
    Mol Pharmacol; 2000 Jul; 58(1):185-93. PubMed ID: 10860941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
    Gbaguidi GF; Agellon LB
    Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of lycopene on the induction of foam cell formation by modified LDL.
    Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
    Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
    J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tumor necrosis factor-alpha on acyl coenzyme A: cholesteryl acyltransferase activity and ACAT1 gene expression in THP-1 macrophages.
    He P; Cheng B; Wang Y; Wang H
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):170-2. PubMed ID: 17497288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.